Menu
Back to User profile » Dr Marie Linder
Papers published by Dr Marie Linder:
Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden
Linder M, Iliadou Nyman A, Kieler H, Danielsson B, Borg N, Gry M, Collin J
Clinical Epidemiology 2020, 12:1029-1038
Published Date: 5 October 2020
The Occurrence of Metabolic Risk Factors Stratified by Psoriasis Severity: A Swedish Population-Based Matched Cohort Study
Hajiebrahimi M, Song C, Hägg D, Andersson TML, Villacorta R, Linder M
Clinical Epidemiology 2020, 12:737-744
Published Date: 13 July 2020
Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
Löfling L, Sundström A, Kieler H, Bahmanyar S, Linder M
Clinical Epidemiology 2019, 11:133-143
Published Date: 23 January 2019
Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers
Hajiebrahimi M, Linder M, Hägg D, Anveden Berglind I, McElligott S, Valgardsson VS, Villacorta R, Sundström A
Clinical Epidemiology 2018, 10:705-715
Published Date: 19 June 2018
Children with hemodynamically significant congenital heart disease can be identified through population-based registers
Bergman G, Hærskjold A, Stensballe LG, Kieler H, Linder M
Clinical Epidemiology 2015, 7:119-127
Published Date: 23 January 2015
Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies
Linder M, Byström C, Kieler H, Bergman G, Haerskjold A
Clinical Epidemiology 2015, 7:45-51
Published Date: 29 December 2014